Image guidance helps clinicians plan and place needles or catheters with precision. Computed tomography, ultrasound, or magnetic resonance can identify the tumor and help limit injury to nearby tissue. This precision supports both local treatment delivery and tissue sampling, making the approach useful when lesions are difficult to reach surgically.
Local treatment choices reflect the clinical goal and the way therapy is delivered. Tumor ablation acts as a tumor-directed treatment, embolization uses a catheter-based route, and targeted drug delivery concentrates therapy locally. Because these options differ in delivery, clinicians can tailor management to the tumor and the broader treatment plan.
Suitability depends on whether surgery or systemic therapy alone can adequately address the cancer, as well as whether a localized intervention can help control disease or symptoms. The approach may be considered for primary or metastatic tumors, and its role can be adjusted within a personalized plan rather than treated as a one-size-fits-all option.
An image-guided intervention generally links three functions: locating the lesion, accessing it with a needle or catheter, and delivering the selected local therapy or obtaining tissue. Computed tomography, ultrasound, or magnetic resonance can provide the guidance. The same image-based framework also supports follow-up assessment by helping clinicians monitor treatment response.
Beyond direct tumor control, interventional oncology can provide tissue sampling, symptom relief, and treatment-response monitoring. These functions make it relevant across different stages of cancer care: clinicians may obtain diagnostic information, address cancer-related problems, or evaluate whether a local treatment is working. Its value therefore extends beyond a single procedure or isolated treatment episode.
Within multidisciplinary cancer care, the specialty can complement rather than replace other treatment approaches. Its image-guided procedures may contribute diagnosis, local tumor control, symptom management, and assessment of response, while treatment selection remains connected to the patient’s broader plan. This coordination is especially relevant when surgery or systemic therapy alone is unsuitable for the disease being managed.